(Q47448931)

16 January 2018

title

Pharmacological inhibition of PTEN limits myocardial infarct size and improves left ventricular function postinfarction (English)

1 reference

16 January 2018

1 reference

Kyle T Keyes

1

1 reference

16 January 2018

Jing Xu

2

1 reference

16 January 2018

Bo Long

3

1 reference

16 January 2018

Congfang Zhang

4

1 reference

16 January 2018

Zhaoyong Hu

5

1 reference

16 January 2018

Yumei Ye

6

1 reference

16 January 2018

publication date

22 January 2010

1 reference

16 January 2018

American Journal of Physiology Heart and Circulatory Physiology

published in

1 reference

16 January 2018

volume

298

1 reference

16 January 2018

issue

4

1 reference

16 January 2018

page(s)

H1198-208

1 reference

16 January 2018

Mitochondrial PKCepsilon and MAPK form signaling modules in the murine heart: enhanced mitochondrial PKCepsilon-MAPK interactions and differential MAPK activation in PKCepsilon-induced cardioprotection

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00915.2009

Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00915.2009

Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00915.2009

The nitric oxide hypothesis of late preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00915.2009

PTEN activity is modulated during ischemia and reperfusion: involvement in the induction and decay of preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00915.2009

Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00915.2009

New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00915.2009

Survival kinases in ischemic preconditioning and postconditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00915.2009

Mediating delta-opioid-initiated heart protection via the beta2-adrenergic receptor: role of the intrinsic cardiac adrenergic cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00915.2009

Acetylcholine and bradykinin trigger preconditioning in the heart through a pathway that includes Akt and NOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00915.2009

Regulation of cell size and contractile function by AKT in cardiomyocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00915.2009

Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00915.2009

Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00915.2009

The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00915.2009

Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00915.2009

PTEN, the Achilles' heel of myocardial ischaemia/reperfusion injury?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00915.2009

Akt1 in the cardiovascular system: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00915.2009

Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00915.2009

The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00915.2009

Inducible and cardiac specific PTEN inactivation protects ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00915.2009

Bisperoxovanadium compounds are potent PTEN inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00915.2009

Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00915.2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00915.2009

Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00915.2009

Down-regulation of PTEN by sodium orthovanadate inhibits ASK1 activation via PI3-K/Akt during cerebral ischemia in rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00915.2009

The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00915.2009

10.1152/AJPHEART.00915.2009

21 January 2018

Identifiers

DOI

1 reference

16 January 2018

PubMed ID

20097771

1 reference

16 January 2018